SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-039148
Filing Date
2019-02-14
Accepted
2019-02-14 06:45:33
Documents
2
Group Members
JONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. IV, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d670615dsc13da.htm SC 13D/A 100264
2 EX-99.A d670615dex99a.htm EX-99.A 7741
  Complete submission text file 0001193125-19-039148.txt   109889
Mailing Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 024511215 7812900770
POLARIS VENTURE PARTNERS IV LP (Filed by) CIK: 0001157864 (see all company filings)

IRS No.: 043571023 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Subject) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88094 | Film No.: 19600589
SIC: 2834 Pharmaceutical Preparations